Home | Welcome to Contract Pharma   
Last Updated Sunday, February 1 2015

Print RSS Feed

Topics - Biologics, Proteins, Vaccines


Refine by Date:
From: To:
Published January 30, 2015
To develop and commercialize JRC2-LAMP-vax to treat allergies Read More »
By Eric S. Langer and Jean-Claude Lupis, BioPlan Associates
Published January 29, 2015
Keep your eye on these trends in 2015. Read More »
Published January 27, 2015
Now provides comprehensive biotherapeutic protein analyses Read More »
Published January 22, 2015
Will research and develop approaches to CAR T cell therapy in cancer Read More »
Published January 21, 2015
Adds a new lab for cell-based assays Read More »
Published January 16, 2015
Gains Funding from Innovative Medicines Initiative Read More »
Published January 15, 2015
Will conduct influenza challenge research at WCCT's Costa Mesa facility Read More »
Published January 15, 2015
Sanofi gains access to capabilities to transfer and manufacture biologics Read More »
Published January 15, 2015
Will apply Catalent’s SMARTag technology in Sanofi’s antibodies Read More »
Published January 14, 2015
Gains exclusive rights to Phase III immuno-oncology compound Read More »
Published January 6, 2015
Will support manufacturing and production of Argos immunotherapies Read More »
Published January 5, 2015
Aims to develop and commercialize next-gen (CAR) T cell immunotherapies Read More »
Published January 5, 2015
Gains preclinical CMV vaccine candidate Read More »
Published December 22, 2014
Expands biopharma CMO business Read More »
Published December 15, 2014
Includes Czech production facility and assets for H5N1, H1N1 and seasonal flu vaccines Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On